These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 12685548
1. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis. Tamada S, Goto M, Nomoto M, Nagata K, Shimizu T, Tanaka S, Sakoda K, Imai K, Yonezawa S. Pathol Int; 2002 Nov; 52(11):713-23. PubMed ID: 12685548 [Abstract] [Full Text] [Related]
2. Expression of mucin antigens in human cancers and its relationship with malignancy potential. Yonezawa S, Sato E. Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463 [Abstract] [Full Text] [Related]
3. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma. Higashi M, Yonezawa S, Ho JJ, Tanaka S, Irimura T, Kim YS, Sato E. Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510 [Abstract] [Full Text] [Related]
4. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Utsunomiya T, Yonezawa S, Sakamoto H, Kitamura H, Hokita S, Aiko T, Tanaka S, Irimura T, Kim YS, Sato E. Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723 [Abstract] [Full Text] [Related]
5. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma. Matsukita S, Nomoto M, Kitajima S, Tanaka S, Goto M, Irimura T, Kim YS, Sato E, Yonezawa S. Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022 [Abstract] [Full Text] [Related]
6. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis. Akyürek N, Akyol G, Dursun A, Yamaç D, Günel N. Pathol Res Pract; 2002 Jan; 198(10):665-74. PubMed ID: 12498221 [Abstract] [Full Text] [Related]
7. MUC1 and MUC2 expression in human gallbladder carcinoma: a clinicopathological study and relationship with prognosis. Kashiwagi H, Kijima H, Dowaki S, Ohtani Y, Tobita K, Yamazaki H, Nakamura M, Ueyama Y, Tanaka M, Inokuchi S, Makuuchi H. Oncol Rep; 2001 Jan; 8(3):485-9. PubMed ID: 11295067 [Abstract] [Full Text] [Related]
8. Expression of mucin carbohydrates and core proteins in carcinomas of the ampulla of Vater: their relationship to prognosis. Kitamura H, Yonezawa S, Tanaka S, Kim YS, Sato E. Jpn J Cancer Res; 1996 Jun; 87(6):631-40. PubMed ID: 8766528 [Abstract] [Full Text] [Related]
9. Immunohistochemical expression of mucin antigens in gallbladder adenocarcinoma: MUC1-positive and MUC2-negative expression Is associated with vessel invasion and shortened survival. Hiraki T, Yamada S, Higashi M, Hatanaka K, Yokoyama S, Kitazono I, Goto Y, Kirishima M, Batra SK, Yonezawa S, Tanimoto A. Histol Histopathol; 2017 Jun; 32(6):585-596. PubMed ID: 27672051 [Abstract] [Full Text] [Related]
10. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance. Zhang HK, Zhang QM, Zhao TH, Li YY, Yi YF. World J Gastroenterol; 2004 Oct 15; 10(20):3044-7. PubMed ID: 15378790 [Abstract] [Full Text] [Related]
11. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact. Park SY, Roh SJ, Kim YN, Kim SZ, Park HS, Jang KY, Chung MJ, Kang MJ, Lee DG, Moon WS. Oncol Rep; 2009 Sep 15; 22(3):649-57. PubMed ID: 19639217 [Abstract] [Full Text] [Related]
12. [Expression of mucin MUC1 and MUC2 in colorectal carcinoma and their clinical significance]. Huang WB, Shi LH, Zhu XQ, Xu GX, Qi Q. Ai Zheng; 2002 Nov 15; 21(11):1231-4. PubMed ID: 12526222 [Abstract] [Full Text] [Related]
13. Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma. Yamashita K, Yonezawa S, Tanaka S, Shirahama H, Sakoda K, Imai K, Xing PX, McKenzie IF, Hilkens J, Kim YS. Int J Cancer; 1993 Aug 19; 55(1):82-91. PubMed ID: 8393843 [Abstract] [Full Text] [Related]
14. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas. Baldus SE, Zirbes TK, Engel S, Hanisch FG, Mönig SP, Lorenzen J, Glossmann J, Fromm S, Thiele J, Pichlmaier H, Dienes HP. Int J Cancer; 1998 Apr 17; 79(2):133-8. PubMed ID: 9583726 [Abstract] [Full Text] [Related]
15. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors]. Yu XW, Rong W, Xu FL, Xu GY, Sun YR, Feng MY. Ai Zheng; 2007 Nov 17; 26(11):1204-10. PubMed ID: 17991319 [Abstract] [Full Text] [Related]
16. Immunohistochemical study of Muc1, Muc2 and human gastric mucin in breast carcinoma: relationship with prognostic factors. Xu Y, Kimura N, Yoshida R, Lin H, Yoshinaga K. Oncol Rep; 2001 Nov 17; 8(5):1177-82. PubMed ID: 11496338 [Abstract] [Full Text] [Related]
17. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation. Chinyama CN, Marshall RE, Owen WJ, Mason RC, Kothari D, Wilkinson ML, Sanderson JD. Histopathology; 1999 Dec 17; 35(6):517-24. PubMed ID: 10583575 [Abstract] [Full Text] [Related]
18. Mucins in neoplasms of pancreas, ampulla of Vater and biliary system. Moschovis D, Bamias G, Delladetsima I. World J Gastrointest Oncol; 2016 Oct 15; 8(10):725-734. PubMed ID: 27795812 [Abstract] [Full Text] [Related]
19. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. Yonezawa S, Nakamura A, Horinouchi M, Sato E. J Hepatobiliary Pancreat Surg; 2002 Oct 15; 9(3):328-41. PubMed ID: 12353144 [Abstract] [Full Text] [Related]
20. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope. Baldus SE, Wienand JR, Werner JP, Landsberg S, Drebber U, Hanisch FG, Dienes HP. Int J Oncol; 2005 Nov 15; 27(5):1289-97. PubMed ID: 16211224 [Abstract] [Full Text] [Related] Page: [Next] [New Search]